TempP

Version vom 1. Februar 2021, 22:57 Uhr

cont as TempP(1)

C7592035 ?. Weitere Metaanalyse zu chinesischer Arzneitherapie bei COVID-19.
C7569105 2020. Kortikosteroide senken die 28-Tage-Mortalität.
C7569096 2020. Remdesivir wirkt bei mittelschwerem Verlauf.
C7569089 2020. Konvaleszentenplasma in Abhängigkeit von der IgG-Konzentration wirksam.
C7574989 ?. COVID-19 ? Therapiemöglichkeiten mit chinesischen Arzneimitteln in der Akutphase und Rekonvaleszenz.
C7565236 2020. Multiple drugs: Coronavirus disease 2019 (COVID-19) and lack of efficacy: case report.
C7565230 2020. Azithromycin/hydroxychloroquine: Cardiac disorders following off label use: 5 case reports.
C7565217 2020. Remdesivir-related acute kidney injury in patients with COVID-19.
C7565214 2020. Adalimumab/methotrexate: COVID-19 infection: case report.
C7565212 2020. Favipiravir/hydroxychloroquine/oseltamivir: Tonic clonic seizures following off label use: case report.
C7561306 ?. Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab?.
C7549423 ?. Begrenzte Evidenz für chinesische Arzneitherapie bei COVID-19: Systematisches Review und Metaanalyse.
C7547645 2020. Unexpected better outcome in a liver transplant recipient with COVID-19: a beneficial effect of tacrolimus??.
C7546940 2020. Antibacterials/chloroquine/tocilizumab: Kidney and hepatic injury: case report.
C7546932 2020. Favipiravir: Hyperuricaemia and acute gouty arthritis following off-label use: case report.
C7546930 2020. Multiple drugs: Lack of efficacy: case report.
C7546926 2020. Hydroxychloroquine: Allergic reaction in the form of erythema multiforme during off label treatment: case report.
C7546924 2020. Azithromycin/hydroxychloroquine/propofol: Off-label use and propofol infusion syndrome: case report.
C7546922 2020. Cladribine/hydroxychloroquine: COVID-19-pneumonia lymphopenia and off label use: case report.
C7546936 2020. Multiple drugs: Lack of efficacy: case report.
C7546931 2020. Hydroxychloroquine: Sinus bradycardia and QTc prolongation following off-label use: case report.
C7546929 2020. Dexamethasone/prednisone/tocilizumab: Worsening of Strongyloides infection: case report.
C7546925 2020. Avelumab/pembrolizumab: COVID-19 infection and recurrent infusion reactions: case report.
C7538275 ?. Matrix metalloproteinase inhibitors identified from Camellia sinensis for COVID-19 prophylaxis: an in silico approach.
C7538068 ?. Virological cure clinical efficacy and safety of Remdesivir supplementation against SARS-CoV 2 infection; evidence from human studies.
C7530884 2020. Methotrexate: Lack of efficacy: case report.
C7530876 2020. Azithromycin: Wide QRS complex tachyarrhythmia following off-label use: case report.
C7530873 2020. Immunosuppressants/Lopinavir/ritonavir: Elevated drug level Covid 19 and reactivation of Herpes Zoster: 2 case reports.
C7530869 2020. Lopinavir/ritonavir/tocilizumab: Hypertriglyceridaemia following off-label use: 2 case reports.
C7530867 2020. Azithromycin/hydroxychloroquine: QTc interval prolongation: case report.
C7530864 2020. Prednisolone: COVID-19 pneumonia: case report.
C7530852 2020. Lopinavir/ritonavir: Maculopapular rash following off-label use: case report.
C7530849 2020. Hydroxychloroquine: Generalised pustular figurate erythema: 2 case reports.
C7530847 2020. Immunosuppressants: COVID-19 and secondary infections: 3 case reports.
C7530882 2020. Azacitidine: No therapeutic response: case report.
C7530878 2020. Hydroxychloroquine- and chloroquine-related cardiovascular events.
C7530875 2020. Hydroxychloroquine in early pregnancy: risk of birth defects.
C7530871 2020. Multiple drugs: Acute pancreatitis hypertriglyceridaemia and off-label use in coronavirus disease 2019: 2 case reports.
C7530868 2020. Monoclonal antibodies: Impaired humoral immunity: 5 case reports.
C7530857 2020. Multiple drugs: Prolonged viral shedding time and off-label use: case report.
C7530850 2020. Paracetamol: No therapeutic response: case report.
C7530844 2020. Immunosuppressants/CAR T-cell therapies: COVID-19 infection: 2 case reports.
C7548860 2020. CORTICOSTEROID TREATMENT IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA.
C7548774 2020. THE USE OF TOCILIZUMAB AT A COMMUNITY HOSPITAL DURING THE COVID-19 PANDEMIC IN THE EPICENTER OF NORTHERN NEW JERSEY.
C7548762 2020. A RECOVERED CASE OF COVID-19 MYOCARDITIS TREATED WITH IV IMMUNOGLOBULIN.
C7548738 2020. THE ASSOCIATION OF IL-6 VALUE INTERLEUKIN INHIBITORS AND OUTCOMES OF PATIENTS WITH COVID-19 IN NEW YORK CITY.
C7548730 2020. COVID-19 VENTILATOR DEPENDENT RESPIRATORY FAILURE SUCCESSFULLY TREATED WITH ANTIINFLAMMATORY BOTANICALS.
C7548673 2020. HYDROXYCHLOROQUINE AND COVID-19: A META-ANALYSIS.
C7548671 2020. TOCILIZUMAB USE IN SEVERE COVID-19: A SINGLE CENTER EXPERIENCE.
C7548587 2020. LUNG ABSCESSES IN A PATIENT TREATED WITH TOCILIZUMAB FOR COVID-19 PNEUMONIA COMPLICATED BY SEVERE HYPOXEMIC RESPIRATORY FAILURE.
C7550165 2020. A REMARKABLE RESPONSE TO ANGIOTENSIN II THERAPY IN SEVERE SARS-COV-2 INFECTION.
C7548795 2020. THE ANTI-INFECTIVE AND IMMUNOMODULATOR PARADOX: INCREASED RISK OF COINFECTION WITH HYDROXYCHLOROQUINE IN CRITICAL PATIENTS WITH COVID-19.
C7548775 2020. HEMOLYTIC ANEMIA AND METHEMOGLOBINEMIA DUE TO HYDROXYCHLOROQUINE USE FOR COVID-19 TREATMENT IN A GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT PATIENT.
C7548709 2020. THE SIGNIFICANCE OF ORAL ASCORBIC ACID IN PATIENTS WITH COVID-19.
C7548682 2020. CONVALESCENT PLASMA THERAPY IN CRITICALLY ILL PATIENTS WITH LATE STAGE COVID-19.
C7548660 2020. IMPROVED SURVIVAL OUTCOME IN PATIENTS WITH SARS-COV-2 (COVID-19) ARDS WITH TOCILIZUMAB ADMINISTRATION.
C7548656 2020. A DRY COUGH CONUNDRUM: A RARE CASE OF PNEUMOCYSTIS JIROVECII PNEUMONIA IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENT ON HYDROXYCHLOROQUINE.
C7548636 2020. ANAPHYLACTIC SHOCK IN A PREGNANT PATIENT WITH COVID-19 IN THE SETTING OF CONVALESCENT PLASMA TRANSFUSION.
C7548634 2020. CYTOMEGALOVIRUS COLITIS POST IL-6 INHIBITOR USE IN COVID-19 INFECTION.
C7548624 2020. NITRIC OXIDE IS A POWERFUL ANTI-CORONAVIRUS-INHALED AGENT THAT ACTS WITHIN HOURS.
C7548604 2020. CORONAVIRUS DISEASE 2019 AND CAVEATS OF IMMUNOMODULATORS.
33487301 2021. Nutritional status assessment in patients with Covid-19 after discharge from the intensive care unit.
C7543043 ?. The potential of lactoferrin ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19.
C7543042 ?. In silico analysis of protein/peptide-based inhalers against SARS-CoV-2.
C7485645 ?. Use of corticosteroid injections in current COVID pandemic ? Time to rethink!!
C7581319 2020. TCT CONNECT-217 Hydroxychloroquine and Azithromycin Usage in African American Patients With Coronavirus Disease 2019 (COVID-19) and Their Effects on QT Interval.
C7590838 ?. Combating COVID-19: The role of drug repurposing and medicinal plants.
33491033 ?. Impact of Serum 25(OH) Vitamin D Level on Mortality in Patients with COVID-19 in Turkey.
C7544924 ?. In silico allicin induced S-thioallylation of SARS-CoV-2 main protease.
C7574546 2020. A new perspective for mitigation of SARS-CoV-2 infection: priming the innate immune system for viral attack.
33380375 ?. Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19?
33485605 ?. Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle.

C7565225 2020. Rituximab: Prolongation and worsening of COVID-2019-infection: case report.
C7565220 2020. Hydroxychloroquine: Acute generalised exanthematous pustulosis following off-label use: case report.
C7565216 2020. Methotrexate: COVID-19 infection: case report.
C7565201 2020. Methotrexate/methylprednisolone/prednisone: Prolonged SARS-CoV-2 infection and masking of the symptoms of SARS-CoV-2 infection: case report.
C7565239 2020. Tocilizumab: Septic shock following off-label use: case report.
C7565232 2020. Hydroxychloroquine: Acute haemolytic anaemia direct Coombs negative following off-label use: case report.
C7529470 2020. Potential therapeutic target identification in the novel 2019 coronavirus: insight from homology modeling and blind docking study.
C7527303 2020. TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19.
C7556163 2020. Unraveling the SARS-CoV-2 Main Protease Mechanism Using Multiscale Methods.
C7586461 ?. SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution.
C7586456 ?. Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped Particles.
C7571299 ?. Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19.
C7571300 ?. Ebselen Disulfiram Carmofur PX-12 Tideglusib and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors.
C7553038 ?. Development of a High-Throughput Homogeneous AlphaLISA Drug Screening Assay for the Detection of SARS-CoV-2 Nucleocapsid.
33496642 2020. Potential role for nitazoxanide in treating SARS-CoV-2 infection.
33349491 ?. Do Systemic Corticosteroids Reduce Mortality in Critically Ill Adult Patients With COVID-19?
C7530554 2020. Belief and Usage of Traditional Chinese Medicine as Preventative Measure against COVID-19 Infection During the Pandemic among Chinese Immigrants in Canada.
C7528906 2020. Hydroxychloroquine and Potential Drug Interactions in Older Adults.
C7527307 ?. Development of multi-epitope peptide-based vaccines against SARS-CoV-2.
C7531593 2021. Potential therapeutic value of dexmedetomidine in COVID-19 patients admitted to ICU.
C7566798 2020. Inflammation malnutrition and SARS-CoV-2 infection: A disastrous combination?.

33072652 2020. Sudden Death Following Suicide with Colchicine and Chloroquine.
32736876 2020. Propiedades antivirales y antiinflamatorias de ivermectina y su potencial uso en COVID-19.
33341233 2020. The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?
33049581 2020. The mechanisms of hydroxychloroquine in rheumatoid arthritis treatment: Inhibition of dendritic cell functions via Toll like receptor 9 signaling.
32621739 2020. Early combination of Tocilizumab and Corticosteroids: An upgrade in anti-inflammatory therapy for severe COVID.
32805024 2020. Implications of COVI-19 antibody dynamics for immunity and convalescent plasma therapy.
33051326 2020. Considerations pour la prise en charge securitaire d'une infection au SRAS-CoV-2 au moyen de chloroquine, d'hydroxychloroquine et d'azithromycine.
33065363 2021. Thioredoxin-albumin fusion protein prevents urban aerosol-induced lung injury via suppressing oxidative stress-related neutrophil extracellular trap formation.
33067760 2020. Child behaviour during dental care under nitrous oxide sedation: a cohort study using two different gas distribution systems.
33117508 2020. Prospects of plasmapheresis for patients with severe COVID-19.
33133107 2020. Editorial: Immune-Modulatory Effects of Vitamin D.
33117343 2020. Azithromycin Differentially Alters TCR-Activated Helper T Cell Subset Phenotype and Effector Function.
33015114 2020. Editorial: Nutrition, Immunity and Viral Infections.
33132549 2020. Tocilizumab and COVID-19.
33061476 2020. Human Umbilical Cord Mesenchymal Stem Cells for Adjuvant Treatment of a Critically Ill COVID-19 Patient: A Case Report.
32916818 2020. mRNA Vaccine Era-Mechanisms, Drug Platform and Clinical Prospection.
32911795 2020. An Update on Vitamin D Metabolism.
33042489 2020. Can Zinc Be an Option for Prevention of Corona Virus Disease 2019?
32869923 2020. A biflavonoid-rich extract from Selaginella moellendorffii Hieron. induces apoptosis via STAT3 and Akt/NF-kappaB signalling pathways in laryngeal carcinoma.
33071519 2020. Repurposing Hepatitis C Direct -acting antivirals against COVID-19.
33111199 2021. Bacillus Calmette-Guerin (BCG) Vaccine-associated Complications in Immunodeficient Patients Following Stem Cell Transplantation.
32932587 2020. Selective Apheresis of C-Reactive Protein for Treatment of Indications with Elevated CRP Concentrations.
32858837 2020. Understanding the Relationship between Glutathione, TGF-beta, and Vitamin D in Combating Mycobacterium tuberculosis Infections.
33073066 2021. Safety of Remdesivir in Patients With Acute Kidney Injury or CKD.
33078031 2021. Optimizing the production of vitamin D in white button mushrooms (Agaricus bisporus) using ultraviolet radiation and measurement of its stability.
33122970 2020. Luteolin Attenuates IL-1beta-Induced THP-1 Adhesion to ARPE-19 Cells via Suppression of NF-kappaB and MAPK Pathways.
32967141 2020. Recent Advances in the Synthesis and Biological Activity of 8-Hydroxyquinolines.
33296987 2020. Benign SARS-CoV-2 infection in MOG-antibodies associated disorder during tocilizumab treatment.
33009505 2020. Convalescent plasma trial shows no benefit.
32933052 2020. Clinical Significance of Analysis of Vitamin D Status in Various Diseases.
32931286 2020. Expanding Access to Remdesivir via an Improved Pyrrolotriazine Synthesis: Supply Centered Synthesis.
32867272 2020. Kinins and Their Receptors in Infectious Diseases.
32937880 2020. Immunostimulating RNA Delivered by P1500 PEGylated Cationic Liposomes Limits Influenza Infection in C57Bl/6 Mice.
33026598 2020. Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects.
33052207 2020. Remdesivir : forme inhalee en pediatrie.
32842641 2020. Plant-Derived Nutraceuticals and Immune System Modulation: An Evidence-Based Overview.